RADYSI
LIVE

Serial Number

79302743

Owner

Ascelia Pharma AB

Attorney

Monica Riva Talley

Filing Date

Dec 14, 2020

Add to watchlist:

No watchlists yet
View on USPTO

RADYSI Trademark

Serial Number: 79302743 • Registration: 6696061

RADYSI is a trademark filed by Ascelia Pharma AB on December 14, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Ascelia Pharma AB (5 trademarks)

Per Albin Hanssons väg 41

Entity Type: 03

Trademark Details

Filing Date

December 14, 2020

Registration Date

April 12, 2022

Published for Opposition

January 25, 2022

Goods & Services

Pharmaceutical and veterinary preparations and substances used for medical purposes, namely, diagnostic agents, diagnostic reagents, contrast media, and contrast agents for use in medical diagnostic imaging in the nature of magnetic resonance imaging; contrast media and contrast agents for use in in-vivo imaging; contrast media and contrast agents for use in in-vitro imaging

Chemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Dec 6, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 20, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 26, 2022 FICS
FINAL DISPOSITION PROCESSED
Aug 26, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 12, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 12, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 25, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jan 22, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 5, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 5, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 20, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 17, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 17, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 17, 2021 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Aug 6, 2021 NREP
REFUSAL PROCESSED BY IB
Jun 28, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 8, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 8, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 8, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 7, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 26, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 22, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 21, 2021 REPR